Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Natl Compr Canc Netw ; 13(2): 184-9, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25691611

ABSTRACT

BACKGROUND: The routine use of chest radiographs (CXRs) in the initial evaluation of asymptomatic patients with febrile neutropenia undergoing hematopoietic stem cell transplant (HSCT) is controversial. OBJECTIVE: The goal of this study was to document the incidence of pneumonia demonstrated on CXR during an initial febrile neutropenic episode in adult patients undergoing HSCT. MATERIALS AND METHODS: Clinical records of 1083 adult patients undergoing autologous (n=766), allogeneic (n=269), or umbilical cord blood HSCT (n=48) between October 1, 2009, and December 31, 2012, were retrospectively reviewed. CXRs obtained at the initial febrile neutropenic episode were evaluated for radiologic features of pneumonia. The presence of clinical symptoms, length of stay (LOS), and readmission rates were assessed. RESULTS: A total of 817 (75%) febrile neutropenic episodes were noted. Of the patients with neutropenic fevers, 455 (55%) had CXRs. Of the 76 patients with respiratory symptoms at the time of CXR, 24 (31.6%) had findings suggestive of pneumonia. None of the 379 CXRs performed in the absence of symptoms revealed an infectious process (P=.0001). Moreover, the mean LOS was 23.8 days for patients receiving a CXR compared with 22.2 days (P=.04) in patients without a CXR. Additionally, in patients who had CXRs, 15.7% were readmitted within 30 days compared with 7.4% in those without CXRs (P=.0004). CONCLUSIONS: Indiscriminate routine CXR at the time of first neutropenic fever in asymptomatic adults undergoing HSCT is unlikely to reveal an infectious process or change clinical practice, and may be associated with increased LOS and readmission rates.


Subject(s)
Febrile Neutropenia/diagnostic imaging , Febrile Neutropenia/etiology , Hematopoietic Stem Cell Transplantation/adverse effects , Radiography, Thoracic , Adult , Aged , Febrile Neutropenia/epidemiology , Female , Humans , Incidence , Length of Stay , Male , Middle Aged , Neoplasms/complications , Neoplasms/therapy , Patient Outcome Assessment , Transplantation Conditioning , Transplantation, Autologous , Transplantation, Homologous , Young Adult
2.
J Oncol Pract ; 9(5): e228-33, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23943893

ABSTRACT

PURPOSE: Inpatient academic medical center care historically has been delivered by faculty physicians in conjunction with physicians in training (house officers [HOs]). Alternative staffing models have emerged secondary to American Counsel for Graduate Medical Education work-hour restrictions. The purpose of this study was to assess the quality of acute myelogenous leukemia (AML) care provided by a physician assistant (PA) service compared with a traditional model. PATIENTS AND METHODS: Data were retrospectively collected on patients admitted with AML for reinduction chemotherapy from 2008 to 2012. Primary outcome measures were inpatient mortality and length of stay (LOS). Secondary measures included readmissions, intensive care unit (ICU) transfers, consults requested, and radiologic studies ordered. RESULTS: Ninety-five patients with AML were reviewed. Forty-seven patients (49.5%) were admitted to the HO service, and 48 patients (50.5%) were admitted to the PA service. Demographic data were similar between services. LOS was significantly different between the services, with a mean of 36.8 days with the HO model compared with 30.9 days with the PA service (P=.03). The 14-day readmission rate also differed significantly; it was 10.6% (five of 47 patients) and zero for the HO and PA models, respectively (P=.03). The mean number of consults with the HO model was 2.11 (range, zero to five) versus 1.47 (range, zero to four) with the PA service (P=.03). Mortality and ICU transfers were not significantly different. CONCLUSION: The data demonstrate equivalent mortality and ICU transfers, with a decrease in LOS, readmission rates, and consults for patients cared for in the PA service. This suggests that the PA service is associated with increased operational efficiency and decreased health service use without compromising health care outcomes.


Subject(s)
Academic Medical Centers/organization & administration , Leukemia, Myeloid, Acute/drug therapy , Physician Assistants , Adult , Aged , Female , Humans , Intensive Care Units/statistics & numerical data , Length of Stay , Leukemia, Myeloid, Acute/mortality , Male , Middle Aged , Outcome Assessment, Health Care , Patient Readmission/statistics & numerical data , Quality of Health Care , Young Adult
3.
Biol Blood Marrow Transplant ; 19(1): 4-11, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23078785

ABSTRACT

The National Marrow Donor Program, in partnership with the American Society for Blood and Marrow Transplantation, sponsored and organized a series of symposia to identify complex issues affecting the delivery of hematopoietic cell transplantation (HCT) and to collaboratively develop options for solutions. "Hematopoietic Cell Transplantation in 2020: A System Capacity Initiative" used a deliberative process model to engage professional organizations, experts, transplant centers, and stakeholders in a national collaborative effort. Year 2 efforts emphasized data analysis and identification of innovative ideas to increase HCT system efficiency, address future capacity requirements, and ensure adequate reimbursement for HCT programs to meet the projected need for HCT. This report highlights the deliberations and recommendations of Year 2 and the associated symposium held in September 2011.


Subject(s)
Delivery of Health Care , Guideline Adherence , Hematopoietic Stem Cell Transplantation , Societies, Medical , Tissue Donors , Congresses as Topic , Delivery of Health Care/economics , Delivery of Health Care/methods , Delivery of Health Care/organization & administration , Female , Guideline Adherence/economics , Guideline Adherence/organization & administration , Guideline Adherence/standards , Humans , Male
4.
Biol Blood Marrow Transplant ; 18(2): 172-82, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22178961

ABSTRACT

Hematopoietic cell transplantation (HCT) is the only known curative therapy for many patients with life-threatening hematologic and oncologic diseases. It is estimated that the National Marrow Donor Program(®) (NMDP) will facilitate 10,000 transplants by 2015, double the current number. To better understand the existing personnel and center infrastructure for HCT in the country and to address system capacity challenges to the future growth of HCT, the NMDP convened a diverse group of stakeholders and thought leaders representing HCT physicians, physician assistants, nurse practitioners, nurses, pharmacists, other healthcare providers, HCT program directors, hospital administrators, payors, and professional organizations. Working groups were formed to identify: capacity issues because of shortages in human resources, structural constraints, and patient access barriers including diversity and healthcare disparity challenges; recommendations to address challenges; and stakeholders to engage. This report details the deliberations and recommendations of a national symposium, "Hematopoietic Cell Transplantation in 2020: A Health Care Resource and Infrastructure Assessment," held in September 2010.


Subject(s)
Bone Marrow , Hematopoietic Stem Cell Transplantation , National Health Programs , Tissue Donors , Congresses as Topic , Female , Humans , Male , Neoplasms/therapy , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...